Primary Cell Culture Global Market Report 2024

The primary cell culture market size has grown rapidly in recent years. It will grow from $5.91 billion in 2023 to $6.79 billion in 2024 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to the increasing demand for monoclonal antibodies, the rise in demand for novel therapeutics, the growing popularity of personalized medicine, and the increasing interest in cell therapy research.

The primary cell culture market size is expected to see rapid growth in the next few years. It will grow to $11.89 billion in 2028 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to the rapid increase in cancer incidence, the rising expansion of pharmaceutical and biotechnology industries, the growing demand for personalized medicine, and the increasing applications in 3D cell culture models. Major trends in the forecast period include technological advancements, product innovation, partnerships, and research and development efforts.

The growth of the primary cell culture market is expected to be driven by the increasing prevalence of chronic diseases. Chronic diseases are enduring conditions that progress slowly and persist over extended periods, often throughout an individual's lifetime. This rise can be attributed to factors such as lifestyle changes, environmental influences, physical inactivity, dietary shifts, and demographic changes. Primary cell cultures play a crucial role in advancing knowledge and treatment strategies for chronic diseases, ultimately enhancing patient outcomes. For example, in January 2023, the National Center For Biotechnology Information estimated that the number of people with at least one chronic disease would increase by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. Therefore, the increasing prevalence of chronic diseases is a key driver of the primary cell culture market.

Leading companies in the primary cell culture market are focusing on developing cell banks containing primary cells specifically for cultivated meat research, aiming to advance sustainable and ethical meat production technologies. The Cell Bank initiative aims to support early-stage companies and researchers by providing high-quality animal primary cells suitable for cultivated meat research and development, at up to 90% lower costs than other cell line providers and free from licensing restrictions. For instance, in June 2023, Extracellular, a UK-based CDMO, introduced low-cost, license-free cell banks to support the cultivated meat sector. These cell banks initially offer cells isolated from cows, pigs, and lambs' fat, muscle, and bone marrow tissues. This collaborative project accelerates the growth of the cultivated meat industry in the UK by increasing cell line availability and enabling innovative technology development without licensing or commercial agreement restrictions.

In April 2023, AnaBios Corporation acquired Cell Systems, further enhancing its portfolio of human tissue and cells to support drug discovery and deepen understanding of cell biology. Cell Systems, a US-based company, provides primary cell and cell culture solutions.

Major companies operating in the primary cell culture market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Sartorius AG, Miltenyi Biotec and CO.KG, STEMCELL Technologies Inc., Cyagen Biosciences Inc., Hi Media Laboratories Pvt. Ltd., PromoCell GmbH, AllCells LLC, BPS Bioscience Inc., MatTek Ltd., Axol Bioscience Ltd., Lifeline Cell Technology Corp., Neuromics Inc., Cell Biologics Inc., ZenBio Inc., Epithelix Sàrl, ReachBio LLC, AcceGen Biotechnology, Biopredic International, ixCells Biotechnologies.

North America was the largest region in the primary cell culture market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the primary cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Primary cell culture involves isolating cells directly from tissues or organisms and cultivating them in a controlled laboratory setting. This process includes obtaining tissues from humans or animals, breaking them down using various methods, and encouraging viable cells to grow in specialized culture vessels with specific media.

The primary cell culture products primarily consist of primary cells, reagents, supplements, and media. Primary cells are valued for maintaining their original phenotype and functions, making them more representative of natural cells and providing reliable results that can be translated into in vivo applications with confidence. These products are used for both animal and human cells. Various techniques for separation and culture include the explant method, enzymatic disaggregation, mechanical separation, and others. They are applied in diverse fields such as tissue culture and engineering, vaccine production, gene therapy, regenerative medicine, drug screening, toxicity testing, cancer research, virology, stem cell therapy, among others. These products are utilized by pharmaceutical and biotechnology companies, academic and research institutes, and other end users.

The primary cell culture market research report is one of a series of new reports that provides primary cell culture market statistics, including primary cell culture industry global market size, regional shares, competitors with a primary cell culture market share, detailed primary cell culture market segments, market trends, and opportunities, and any further data you may need to thrive in the primary cell culture industry. This primary cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The primary cell culture market consists of revenues earned by entities by provide services such as adherent cell culture service, suspension cell culture service, cell purification, and analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary cell culture market also includes sales of cell culture vessels, human platelet lysate, and cell culture plastics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.